BioSpace News Archive

The agency found that more than 2.8 million antibiotic-resistant infections occurred in the U.S. each year, killing more than 35,000 people.

The company discontinued development earlier this year, but a shortage prompted the reversal.

Unfortunately, you’re not going to get along with everyone. But when you figure out how to communicate and both know what to expect, it goes a long way in smoothing out what could be a rocky ride.

Life sciences companies strengthen their leadership teams with this week’s appointments.

Antibiotic resistance continues to grow as a public health threat; local health department efforts critical to addressing issue

Circulating Tumor Cells (CTC) analysis has great potential to transform the cancer diagnostic landscape

Researchers can now tap new disease discoveries using Medley Genomics HotNet2 at enterprise scale, over any system, across distributed data with Lifebit CloudOS

Global contract development and manufacturing organisation Recipharm, has announced that it is joining the AMR Industry Alliance as part of its ambition to contribute to exploring solutions to tackle growing concerns around antimicrobial resistance

Athersys, Inc. announced that its collaborator in Japan, HEALIOS K.K. received notification this week from the Pharmaceutical Affairs and Food Sanitation Council that its acute respiratory distress syndrome clinical program using HLCM051, will receive the orphan regenerative medicine designation from the Ministry of Health, Labour and Welfare within the next few weeks.

Digirad Corporation reported its financial results for the third quarter and nine months ended September 30, 2019.